Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02719821 · ClinicalTrials.gov registry record · NA

Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT02719821: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT02719821 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02719821, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The goal of this project is to refine and evaluate the feasibility of a brief, behavioral intervention to improve the recovery following hematopoietic stem cell transplantation (HSCT). Cancer patients who were treated with HSCT will learn behavioral techniques to improve sleep and increase daytime activity with the goal of alleviating insomnia, fatigue, and depression after HSCT. If the intervention is feasible and acceptable to patients, a future study will test the effects in a larger trial, with the long-term goal of improving the care and quality of life of cancer survivors recovering from HSCT.

Primary Outcome

Recruitment rate, reasons for non-participation, and attrition will be tracked at Retention rates and those contributing complete data will be tracked at milestones throughout the study period.

Interventions

  • BEHAVIORAL Behavioral techniques

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2016-03
Est. Completion 2017-06-02
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT02719821 record still lists

NCT02719821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavioral techniques is the first listed.

NCT02719821 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02719821 about?

NCT02719821 is a clinical study titled "Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation". The goal of this project is to refine and evaluate the feasibility of a brief, behavioral intervention to improve the recovery following hematopoietic stem cell transplantation (HSCT). Cancer patients who were treated with HSCT will learn behavioral techniques to improve sleep and increase daytime a...

What is the current status of trial NCT02719821?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2016-03. Estimated completion is 2017-06-02.

What interventions are being tested in trial NCT02719821?

The interventions under investigation include: Behavioral techniques (BEHAVIORAL).

Who is sponsoring clinical trial NCT02719821?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02719821's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02719821, the US trial registry maintained by the National Library of Medicine. NCT02719821 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.